Ventriculoperitoneal shunt infections with gram-negative bacteria

Area of Science:

• Neuroscience
• Infectious Diseases
• Pediatric Surgery

Background:

• Cerebrospinal fluid (CSF) shunts are crucial for managing hydrocephalus but are susceptible to infection.
• Gram-negative bacteria (GNB) are common causes of CSF shunt infections, historically associated with poor patient outcomes.

Purpose of the Study:

• To evaluate the clinical presentation, treatment, and outcomes of Gram-negative bacteria (GNB) cerebrospinal fluid (CSF) shunt infections.
• To identify predictors of persistent infection and assess the efficacy of current treatment protocols.

Main Methods:

• Retrospective review of pediatric patients with GNB CSF shunt infections from January 1986 to January 1990.
• Analysis of clinical symptoms, microbiological data, treatment strategies (shunt removal, external ventricular drainage, antibiotics), and patient outcomes.

Main Results:

• Most infections (87%) occurred within 4 weeks of shunt revision.
• Escherichia coli and Klebsiella pneumoniae were the most common GNB pathogens.
• Prompt shunt removal, externalized ventricular drainage, and intravenous antibiotics led to a 100% cure rate with minimal neurological sequelae (11% CNS damage).
• Low CSF glucose (<10 mg/dl) and positive Gram stain predicted persistent positive CSF cultures despite treatment.

Conclusions:

• Gram-negative bacteria (GNB) CSF shunt infections, though potentially severe, are treatable with a high success rate.
• Early recognition and aggressive management, including shunt removal and drainage, are critical for favorable outcomes.
• Specific clinical indicators (low CSF glucose, positive Gram stain) can predict challenging cases requiring intensified management.